Interstitial lung disease (ILD) is one of the most serious pulmonary complications associated
with connective tissue diseases (CTDs), resulting in significant morbidity and mortality …

Objective To review published cases of induced or exacerbated interstitial lung disease
(ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying …

Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1%
of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary …

Rheumatoid arthritis (RA) is an immune-mediated disease involving chronic low-grade
inflammation that may progressively lead to joint destruction, deformity, disability and even …

Interstitial lung disease (ILD) is a serious complication of rheumatoid arthritis (RA)
contributing to significantly increased morbidity and mortality. Other respiratory …

In the lungs, parenchymal and vascular remodelling share pathomechanisms that may
explain the relatively high prevalence (30–40%) of pulmonary hypertension (PH) in …

Background Anti-tumour necrosis factor (anti-TNF) therapy has been associated with reports
of rapid severe progression of rheumatoid arthritis-associated interstitial lung disease (RA …

Background Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is associated
with high levels of morbidity and mortality. The primary aim of this systematic review was to …

The connective tissue disorders (CTDs), also called collagen vascular diseases (CVDs),
represent a heterogeneous group of immunologically mediated inflammatory disorders with …

Rheumatoid arthritis (RA) is a systemic autoimmune disease affecting 0.5–1% of the
worldwide population. Whilst predominantly causing chronic pain and inflammation in …